Organophosphate Poisoning
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes7
- Organophosphate Poisoning2
- Status Epilepticus2
- Brain Injuries1
- Nerve Agents1
- Neuroprotective Agents1
- Neurosteroids1
- Organothiophosphorus Compounds1
Leading journals1
- The Journal of pharmacology and experimental therapeutics2
Leading researchers5
- Ramakrishnan S2
- Reddy DS2
- Singh T2
- Wu X2
- Huber M1
Affiliations (unnormalised)2
- Department of Neuroscience and Experimental Therapeutics and Institute of Pharmacology and Neurotherapeutics1
- Texas A&M University School of Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Poisoning due to exposure to ORGANOPHOSPHORUS COMPOUNDS, such as ORGANOPHOSPHATES; ORGANOTHIOPHOSPHATES; and ORGANOTHIOPHOSPHONATES.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.